David Sachs

David Sachs joined ImmunityBio as its Chief Financial Officer in July 2019. He offers over two decades of operating, development and investing experience as a finance, private equity, venture capital and investment banking executive. Previously, Sachs served as CFO for several NantWorks subsidiaries, including NantHealth (Nasdaq: NH) and Integrity Healthcare. He also served as a principal and executive at NantCapital, acting as a member of the investment committee. Prior to his roles with NantWorks, Sachs was an investment banker for Bank of America Merrill Lynch, holding senior operating roles at Abraxis BioScience and Celgene (Now Bristol Myers Squibb). He currently serves as a Director of Ziosoft, KK, Mox Networks, LLC, Packetfabric, Inc., and the Chan Soon-Shiong Medical Center at Windber. Sachs received his MBA in Finance and Strategy from the UCLA Anderson School of Management and his BA in Economics from the University of California at Los Angeles.